Topic / Progressive Multifocal Leukoencephalopathy

You are here: Home » Topic » Progressive Multifocal Leukoencephalopathy

Progressive Multifocal Leukoencephalopathy trends

Progressive Multifocal Leukoencephalopathy related content:

Progressive Multifocal Leukoencephalopathy stories:

US warns of risk rise with more Tysabri infusions
Feb 5th, 2010 - Reuters
for tysabri will be updated to warn of the higher risk with more treatment, the food and drug administration said. elan corp co-markets the drug. the fda said the warning was based on 31 confirmed cases of progressive multifocal leukoencephalopathy (pml
FDA Adds PML Risk to MS Drug Label
Feb 5th, 2010 - MedPage Today
washington -- a warning of a risk of progressive multifocal leukoencephalopathy has been added to the label for the multiple sclerosis drug natalizumab (tysabri), the fda announced. the warning notes that the risk of pml increases with the number
FDA: Rare Brain Infection Rises With Tysabri Doses
Feb 5th, 2010 - Wall Street Journal
increase, the u.s. food and drug administration said in a letter to doctors friday. the fda said it has confirmed 31 cases of progressive multifocal leukoencephalopathy, or pml, a rare brain infection, in patients taking the multiple sclerosis
FDA warns of brain risks with frequent Tysabri use
Feb 5th, 2010 - Telegram
of progressive multifocal leukoencephalopathy, or pml, which can cause swelling of the brain that is usually fatal. it is mostly seen in patients with immune deficiencies. the biotech drug is marketed by cambridge, mass.-based biogen idec inc. and irish

Google Search:

Progressive Multifocal Leukoencephalopathy videos from YouTube:

58:41
Progressive Multifocal Leukoencephalopathy
Dr. Joseph R. Berger, chair of the Department of Neurology at the University of Kentucky, studies neurological disorders such as progressive multifocal leukoencephalopathy. PML, a rare viral disease, can affect those individuals with compromised immune systems ...
9:44
PML Progressive Multifocal Leukoencephalopathy
PLEASE HELP NO MATTER HOW SMALL (it is TAX detuctable) This is a personal video of what this disease is about and where to fund it. NORD 55 Kenosia Ave. PO Box 1968 Danbury, CT 06813-1968 All checks should have "for restricted research for PML" written on the memo line ...
2:00
Rituxan Linked to PML (Progressive Multifocal Leukoencephalopathy) Brain Infections
The FDA warns of serious viral brain infection (Progressive Multifocal Leukoencephalopathy) in Rituxan patients. Learn more: www.schmidtandclark.com

Progressive Multifocal Leukoencephalopathy from WikiPedia:

Progressive multifocal leukoencephalopathy (PML), also known as progressive multifocal leukoencephalitis, is a rare and usually fatal viral disease that is characterized by progressive damage (-pathy) or inflammation of the white matter (leuko-) of the brain (-encephalo-) at multiple locations (multifocal). It occurs almost exclusively in people with severe immune deficiency, e.g. transplant patients on immunosuppressive medications, patients receiving certain kinds of chemotherapy, patients receiving Natalizumab (Tysabri) for multiple sclerosis, psoriasis patients on long-term Efalizumab (Raptiva) or AIDS patients.

It is caused by the JC virus.

The cause of PML is a type of polyomavirus called the JC virus (JCV), after the initials of the patient from whose tissue the virus was first successfully cultured.